Apollo Contributes to G Overhang Maintenance and Protects Leading-End Telomeres

Mammalian telomeres contain a single-stranded 3′ overhang that is thought to mediate telomere protection. Here we identify the TRF2-interacting factor Apollo as a nuclease that contributes to the generation/maintenance of this overhang. The function of mouse Apollo was determined using Cre-mediated...

Full description

Saved in:
Bibliographic Details
Published inMolecular cell Vol. 39; no. 4; pp. 606 - 617
Main Authors Wu, Peng, van Overbeek, Megan, Rooney, Sean, de Lange, Titia
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 27.08.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mammalian telomeres contain a single-stranded 3′ overhang that is thought to mediate telomere protection. Here we identify the TRF2-interacting factor Apollo as a nuclease that contributes to the generation/maintenance of this overhang. The function of mouse Apollo was determined using Cre-mediated gene deletion, complementation with Apollo mutants, and the TRF2-F120A mutant that cannot bind Apollo. Cells lacking Apollo activated the ATM kinase at their telomeres in S phase and showed leading-end telomere fusions. These telomere dysfunction phenotypes were accompanied by a reduction in the telomeric overhang signal. The telomeric functions of Apollo required its TRF2-interaction and nuclease motifs. Thus, TRF2 recruits the Apollo nuclease to process telomere ends synthesized by leading-strand DNA synthesis, thereby creating a terminal structure that avoids ATM activation and resists end-joining. These data establish that the telomeric overhang is required for the protection of telomeres from the DNA damage response. ► The shelterin-associated Apollo/SNM1B nuclease was removed from mouse telomeres ► Apollo removal diminished the 3′ overhang and activated the ATM kinase in S phase ► Without Apollo, telomeres generated by leading-strand synthesis underwent fusions ► Thus, shelterin recruits Apollo to protect newly synthesized leading-end telomeres
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Present address: Health Science Communications, 711 Third Avenue, New York, NY 10017. SRooney@health-ny.com.
Present address: Department of Molecular Biology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065. vanoverm@mskcc.org
contributed equally.
ISSN:1097-2765
1097-4164
DOI:10.1016/j.molcel.2010.06.031